Mis à jour le Oct 25, 2023
New app architecture: Receive guidance in a disease- and product-specific step by step process through numerous indications and product-specific content
Eligibility tool: Upon entering relevant clinical criteria for patient eligibility learn about approved CAR T-cell products and Bispecifics for your patient
Grading of hematotoxicity: Refer to new ICAHT classification
Management of COVID-19: Get treatment and management recommendations
